For this week's installment of the BCI's Thursday Seminar Series, Prof. Mark Cragg - Professor of Experimental Cancer Research and Director of the i4PhD Cancer Immunology Pathway - shall be speaking. Prof. Cragg's research group is interested in two main areas: antibodies and small molecule inhibitors with the aim of understanding how these therapeutics function […]